Wenzhou Kangning Hospital Co., Ltd. (FRA:4WK)
Germany · Delayed Price · Currency is EUR 1.010
0.00 (0.00%)
At close: Jan 26, 2026
Wenzhou Kangning Hospital Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,443 | 1,518 | 1,485 | 1,367 | 1,203 | 935.61 |
Other Revenue | 120.85 | 136.52 | 111.1 | 118.09 | 94.66 | 53.4 |
| 1,564 | 1,654 | 1,596 | 1,485 | 1,297 | 989.01 | |
Revenue Growth (YoY) | -5.06% | 3.64% | 7.50% | 14.45% | 31.18% | 14.91% |
Cost of Revenue | 1,173 | 1,227 | 1,197 | 1,140 | 976.16 | 733.72 |
Gross Profit | 391.37 | 427.48 | 399.3 | 344.88 | 321.27 | 255.29 |
Selling, General & Admin | 237.2 | 226.4 | 218.29 | 212.84 | 178.98 | 131.95 |
Research & Development | 34.59 | 36.52 | 32.47 | 33.03 | 27.96 | 20.92 |
Other Operating Expenses | -8.08 | -0.92 | -9.5 | 4.65 | 5.62 | -3.85 |
Operating Expenses | 283.46 | 281.11 | 248.43 | 261.79 | 215.57 | 149.72 |
Operating Income | 107.92 | 146.37 | 150.87 | 83.1 | 105.7 | 105.57 |
Interest Expense | -44.56 | -49.5 | -45.63 | -45.15 | -36.27 | -26.81 |
Interest & Investment Income | 3.93 | 3.88 | 5.27 | 5.61 | 8.63 | 4.68 |
Currency Exchange Gain (Loss) | -0.06 | -0.16 | 0 | 0.08 | -0.04 | -0.26 |
Other Non Operating Income (Expenses) | 7.02 | -8.4 | -1.07 | -15.93 | -2.18 | -0.7 |
EBT Excluding Unusual Items | 74.25 | 92.19 | 109.44 | 27.71 | 75.85 | 82.47 |
Impairment of Goodwill | -5.75 | -5.75 | - | -10.35 | -6.18 | -8.01 |
Gain (Loss) on Sale of Investments | -10.44 | -11.02 | -5.85 | -15.98 | 9.42 | -0.37 |
Gain (Loss) on Sale of Assets | 1.26 | -0.07 | 0.07 | 0.41 | -0.08 | 0.6 |
Asset Writedown | -1.51 | -0.96 | -0.26 | -1.57 | -0.01 | - |
Other Unusual Items | -9.23 | -6.29 | -4.21 | 15.39 | 16.7 | -0.37 |
Pretax Income | 48.57 | 68.1 | 99.18 | 15.6 | 95.69 | 74.32 |
Income Tax Expense | 16.4 | 17.7 | 12.25 | 26.57 | 54.83 | 30.66 |
Earnings From Continuing Operations | 32.17 | 50.4 | 86.93 | -10.97 | 40.86 | 43.66 |
Minority Interest in Earnings | 19.25 | 15.21 | -0.98 | -13.25 | 3.18 | 12.11 |
Net Income | 51.42 | 65.61 | 85.95 | -24.22 | 44.04 | 55.77 |
Net Income to Common | 51.42 | 65.61 | 85.95 | -24.22 | 44.04 | 55.77 |
Net Income Growth | -44.67% | -23.66% | - | - | -21.04% | -2.65% |
Shares Outstanding (Basic) | 73 | 74 | 75 | 75 | 72 | 72 |
Shares Outstanding (Diluted) | 73 | 74 | 75 | 75 | 75 | 74 |
Shares Change (YoY) | -1.76% | -0.43% | - | - | 0.91% | - |
EPS (Basic) | 0.70 | 0.88 | 1.15 | -0.32 | 0.61 | 0.77 |
EPS (Diluted) | 0.70 | 0.88 | 1.15 | -0.32 | 0.59 | 0.75 |
EPS Growth | -43.94% | -23.48% | - | - | -21.33% | -2.60% |
Free Cash Flow | 2.96 | -92.54 | 85.3 | -9.69 | 15.36 | 11.7 |
Free Cash Flow Per Share | 0.04 | -1.25 | 1.14 | -0.13 | 0.21 | 0.16 |
Dividend Per Share | 0.480 | 0.450 | 0.400 | - | - | - |
Dividend Growth | 6.67% | 12.50% | - | - | - | - |
Gross Margin | 25.02% | 25.84% | 25.01% | 23.23% | 24.76% | 25.81% |
Operating Margin | 6.90% | 8.85% | 9.45% | 5.60% | 8.15% | 10.67% |
Profit Margin | 3.29% | 3.97% | 5.38% | -1.63% | 3.39% | 5.64% |
Free Cash Flow Margin | 0.19% | -5.59% | 5.34% | -0.65% | 1.18% | 1.18% |
EBITDA | 192.82 | 234.08 | 223.82 | 159.12 | 168.51 | 160.71 |
EBITDA Margin | 12.33% | 14.15% | 14.02% | 10.72% | 12.99% | 16.25% |
D&A For EBITDA | 84.9 | 87.71 | 72.95 | 76.02 | 62.81 | 55.14 |
EBIT | 107.92 | 146.37 | 150.87 | 83.1 | 105.7 | 105.57 |
EBIT Margin | 6.90% | 8.85% | 9.45% | 5.60% | 8.15% | 10.67% |
Effective Tax Rate | 33.76% | 25.99% | 12.35% | 170.29% | 57.30% | 41.26% |
Revenue as Reported | 1,564 | 1,654 | 1,596 | 1,485 | 1,297 | 989.01 |
Advertising Expenses | - | 3.7 | 4.5 | 3.53 | 2.99 | 2.91 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.